Approval · Notice of Compliance 19940 · 2017
OCREVUS: Notice of Compliance 19940
Issued August 14, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19940
- Date
- August 14, 2017
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OCREVUS | Not yet assigned | — |
Medicinal ingredients
- OCRELIZUMAB 30 MG per ML